Friday, July 10, 2026

pharma · Weight management · Short Bowel Syndrome

Zealand Pharma

Zealand Pharma A/S is a pharma organization headquartered in EU. Primary therapeutic focus areas include Weight management, Short Bowel Syndrome, Children with congenital hyperinsulinism, Critically Ill, Mechanically Ven

Sydmarken 11, Søborg (Copenhagen), 2860, DK HQ
1998 Founded
596 Employees
EMA registrant Type
Company details
Status
Public
HQ
Sydmarken 11, Søborg (Copenhagen), 2860, DK
Founded
1998
Employees
596
Programs
18
Drugs
20
Patents
0
Clinical program

Vitamin C

Phase 2 · small molecule · Shock, Septic

Vitamin C for Shock, Septic is a Phase 2 program (small_molecule) at Zealand Pharma A/S with 1 ClinicalTrials.gov record(s).

← All Zealand Pharma A/S projects Phase 2 small molecule completed

Internal code HREC17Austin238

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Zealand Pharma A/S
Phase
Phase 2
Modality
small_molecule
Indication
Shock, Septic
Status
completed
Trials
1